PubMed (GeneRIF) for id: 6311

Year	Number of Results
2001	2
2002	2
2003	4
2004	7
2005	6
2006	3
2007	8
2008	4
2009	6
2010	8
2011	16
2012	15
2013	9
2014	15
2015	10
2016	12
2017	7
2018	7
2019	6
2020	8
2021	6
2022	4
2023	1
2024	0

1

ATXN2 is a target of N-terminal proteolysis.

Chitre M, Emery P. Chitre M, et al. PLoS One. 2023 Dec 21;18(12):e0296085. doi: 10.1371/journal.pone.0296085. eCollection 2023. PLoS One. 2023. PMID: 38128014 Free PMC article.

2

ATXN2-Mediated PI3K/AKT Activation Confers Gastric Cancer Chemoresistance and Attenuates CD8⁺ T Cell Cytotoxicity.

Wang Q, Cao T, Zhang X, Hui J, Wang C, Zhang W, Wang P, Zhou Y, Han S. Wang Q, et al. J Immunol Res. 2022 Sep 28;2022:6863240. doi: 10.1155/2022/6863240. eCollection 2022. J Immunol Res. 2022. PMID: 36213324 Free PMC article.

3

ATXN2 intermediate expansions in amyotrophic lateral sclerosis.

Glass JD, Dewan R, Ding J, Gibbs JR, Dalgard C, Keagle PJ, Shankaracharya, García-Redondo A, Traynor BJ, Chia R, Landers JE. Glass JD, et al. Brain. 2022 Aug 27;145(8):2671-2676. doi: 10.1093/brain/awac167. Brain. 2022. PMID: 35521889 Free PMC article.

4

VNTR (CAG)n polymorphism of the ATXN2 gene and metabolic parameters of cardiovascular risk associated with the degree of obesity in the Amerindian population of Oaxaca.

Dávalos-Rodríguez NO, Rincón-Sánchez AR, Madrigal Ruiz PM, Flores-Alvarado LJ, López-Toledo S, Villafán-Bernal JR, Castro-Juárez CJ, Guzmán-López R, Siliceo-Murrieta JI, Ramirez-Garcia SA. Dávalos-Rodríguez NO, et al. Endocrinol Diabetes Nutr (Engl Ed). 2022 Jan;69(1):15-24. doi: 10.1016/j.endien.2021.04.001. Epub 2022 Feb 18. Endocrinol Diabetes Nutr (Engl Ed). 2022. PMID: 35232555

5

ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m⁶A-dependent manner.

Li R, Zeng L, Zhao H, Deng J, Pan L, Zhang S, Wu G, Ye Y, Zhang J, Su J, Zheng Y, Deng S, Bai R, Zhuang L, Li M, Zuo Z, Lin D, Zheng J, Huang X. Li R, et al. Mol Ther. 2022 Mar 2;30(3):1089-1103. doi: 10.1016/j.ymthe.2022.01.006. Epub 2022 Jan 4. Mol Ther. 2022. PMID: 34995801 Free PMC article.

6

Spinocerebellar ataxia type 2 from an evolutionary perspective: Systematic review and meta-analysis.

Sena LS, Dos Santos Pinheiro J, Hasan A, Saraiva-Pereira ML, Jardim LB. Sena LS, et al. Clin Genet. 2021 Sep;100(3):258-267. doi: 10.1111/cge.13978. Epub 2021 May 27. Clin Genet. 2021. PMID: 33960424

7

DDX6 is a positive regulator of Ataxin-2/PAPD4 cytoplasmic polyadenylation machinery.

Inagaki H, Hosoda N, Hoshino SI. Inagaki H, et al. Biochem Biophys Res Commun. 2021 May 14;553:9-16. doi: 10.1016/j.bbrc.2021.03.066. Epub 2021 Mar 20. Biochem Biophys Res Commun. 2021. PMID: 33756349

8

LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2.

Fang L, Wang SH, Cui YG, Huang L. Fang L, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1861-1868. doi: 10.26355/eurrev_202102_25081. Eur Rev Med Pharmacol Sci. 2021. PMID: 33660796 Free article.

9

Redox-mediated regulation of low complexity domain self-association.

Kato M, Tu BP, McKnight SL. Kato M, et al. Curr Opin Genet Dev. 2021 Apr;67:111-118. doi: 10.1016/j.gde.2020.12.006. Epub 2021 Jan 14. Curr Opin Genet Dev. 2021. PMID: 33454579 Free PMC article. Review.

10

Expanded CAG Repeats in ATXN1, ATXN2, ATXN3, and HTT in the 1000 Genomes Project.

Akçimen F, Ross JP, Liao C, Spiegelman D, Dion PA, Rouleau GA. Akçimen F, et al. Mov Disord. 2021 Feb;36(2):514-518. doi: 10.1002/mds.28341. Epub 2020 Nov 7. Mov Disord. 2021. PMID: 33159825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

142 results

Results by year